Prestige BioPharma, New KOSPI Listing on the 5th
[Asia Economy Reporter Kim Ji-hee] The Korea Exchange announced on the 3rd that it will list Prestige BioPharma's domestic Depositary Receipts (KDR) on the KOSPI market on the 5th. The public offering price is 32,000 KRW.
Prestige BioPharma is a Singapore-based pharmaceutical company developing biosimilars and antibody drugs.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Penalty Surcharges to Exceed Illicit Gains for Hoarding... Government Announces Strong Response to Market Disruption
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The opening price will be determined between 8:30 AM and 9:00 AM on the listing day by accepting bids within 90% to 200% of the public offering price, and set at the price where sell and buy bids match.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
